Sangamo Therapeutics (SGMO) Reports Q2 Loss of $0.26
Tweet
Share
E-mailGet Alerts SGMO Hot Sheet
Price: $0.18 --0%
Revenue Growth %: -5.7%
Financial Fact:
Total revenues: 2.82M
Today's EPS Names:
ECX, ONON, LODE, More
Revenue Growth %: -5.7%
Financial Fact:
Total revenues: 2.82M
Today's EPS Names:
ECX, ONON, LODE, More
Join SI Premium – FREE
Sangamo Therapeutics (NASDAQ: SGMO) reported Q2 EPS of ($0.26), versus ($0.26) reported last year. Revenue for the quarter came in at $21.55 million, versus $17.55 million reported last year.
For earnings history and earnings-related data on Sangamo Therapeutics (SGMO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- William Blair Downgrades On Holding AG (ONON) to Market Perform
- Imunon (IMNN) Tops Q2 EPS by 39c
- Kalaris Therapeutics (KLRS) Tops Q2 EPS by 2c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
